Cargando…

Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review

A 59-year-old non-obese Japanese woman developed diabetes mellitus with a negative glutamic acid decarboxylase autoantibody (GADA) test result. Her hyperglycemia was initially well controlled by oral hypoglycemic agents; however, despite continued treatment the hyperglycemia gradually worsened. As s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Michi, Ohara, Nobumasa, Ikeda, Yohei, Nagano, Ouki, Takada, Toshinori, Kodama, Makoto, Sone, Hirohito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355411/ https://www.ncbi.nlm.nih.gov/pubmed/30101912 http://dx.doi.org/10.2169/internalmedicine.1008-18

Ejemplares similares

Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer
por: Ohara, Nobumasa, et al.
Publicado: (2019)

Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature
por: Ohara, Nobumasa, et al.
Publicado: (2019)

Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes
por: Takehana, Nobuaki, et al.
Publicado: (2023)

Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodies
por: Aoyama, Tomohisa, et al.
Publicado: (2012)

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017)

α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals
por: Doliba, Nicolai M., et al.
Publicado: (2022)

Unstable bodyweight and incident type 2 diabetes mellitus: A meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2017)

A 75-Year-Old Woman with a 5-Year History of Controlled Type 2 Diabetes Mellitus Presenting with Polydipsia and Polyuria and a Diagnosis of Central Diabetes Insipidus
por: Ohara, Nobumasa, et al.
Publicado: (2022)

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
Publicado: (1993)

A Rare Case of Cerebellar Ataxia Due to Voltage-Gated Calcium Channel and Glutamic Acid Decarboxylase Autoantibodies
por: Annunziata, Giuseppe, et al.
Publicado: (2017)

Hypoglycemic Hemiplegia Associated with Reversible Narrowing of the Contralateral Middle Cerebral Artery in a Patient with Adrenal Insufficiency
por: Sakurai, Yuhki, et al.
Publicado: (2022)

Quantitative Relationship Between Cumulative Risk Alleles Based on Genome-Wide Association Studies and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
por: Kodama, Satoru, et al.
Publicado: (2018)

Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma‐associated antigen‐2 autoantibodies in the identification and characterization of Japanese type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
por: Jonsdottir, Berglind, et al.
Publicado: (2019)

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function
por: Zhu, Yuxiao, et al.
Publicado: (2020)

Three Distinct Glutamate Decarboxylase Genes in Vertebrates
por: Grone, Brian P., et al.
Publicado: (2016)

Molecular Analysis of Glutamate Decarboxylases in Enterococcus avium
por: Gu, Xinyi, et al.
Publicado: (2021)

Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2011)

Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme‐linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity
por: Kawasaki, Eiji, et al.
Publicado: (2019)

Slowly, slowly in the wind /
por: Highsmith, Patricia, 1921-1995
Publicado: (1981)

Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies
por: Herard, Kimberly, et al.
Publicado: (2019)

Parallel Strategy Increases the Thermostability and Activity of Glutamate Decarboxylase
por: Zhang, Qing-Fei, et al.
Publicado: (2020)

Reversible Non-parkinsonian Bradykinesia with Impaired Frontal Lobe Function as the Predominant Manifestation of Adrenal Insufficiency
por: Ohara, Nobumasa, et al.
Publicado: (2018)

Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review
por: Ohara, Nobumasa, et al.
Publicado: (2017)

Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus
por: Trabucchi, Aldana, et al.
Publicado: (2019)

Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995)

Calmodulin-dependent and calmodulin-independent glutamate decarboxylases in apple fruit
por: Trobacher, Christopher P, et al.
Publicado: (2013)

Anti-glutamic acid decarboxylase antibody positive neurological syndromes
por: Tohid, Hassaan
Publicado: (2016)

Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023)

Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives
por: Nishimura, Akihiro, et al.
Publicado: (2019)

Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
por: Eising, Stefanie, et al.
Publicado: (2011)

Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population
por: Yamamura, So, et al.
Publicado: (2019)

Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase
por: Jaeckel, Elmar, et al.
Publicado: (2003)

Limbic encephalitis with antibodies to glutamic acid decarboxylase presenting with brainstem symptoms
por: Incecik, Faruk, et al.
Publicado: (2015)

Identification and molecular cloning of glutamate decarboxylase gene from Lactobacillus casei
por: Tavakoli, Yasaman, et al.
Publicado: (2015)

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression
por: Wu, Xueyan, et al.
Publicado: (2017)

Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies
por: Falip, Mercè, et al.
Publicado: (2019)

Global knockdown of glutamate decarboxylase 67 elicits emotional abnormality in mice
por: Miyata, Shigeo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eper9mnemh3sbir9rm7u5ikpnb